Forecasting the Multidimensional Burdens of Hospital Admissions in LRTIs and COPD: Projections of Healthcare Expenditures, Resource Utilization, and Socioeconomic and Environmental Outcomes for Switzerland [0.03%]
多维度负担的下呼吸道感染和慢性阻塞性肺疾病住院费用预测：对瑞士医疗支出、资源利用和社会经济及环境结果的预测
Desiree Schnidrig,Thomas Campbell-James,Josia D Schramm et al.
Desiree Schnidrig et al.
Introduction: Hospital admissions due to lower respiratory tract infections (LRTIs) and chronic obstructive pulmonary disease (COPD) represent a substantial healthcare challenge for Switzerland. Demographic shift is expec...
Real-World Multicenter Study on the Effectiveness of Dolutegravir Plus Lamivudine in Treatment-Naive People Living with HIV with Baseline HIV-1 RNA > 500,000 Copies/mL [0.03%]
一项关于多替拉韦联合拉米夫定治疗初治且基线病毒载量高于500,000拷贝/毫升的HIV感染者的实效性多中心研究
Bichen Xue,Rui Jiang,Yanyun Dou et al.
Bichen Xue et al.
Introduction: Dolutegravir (DTG) plus lamivudine (3TC) is one of the preferred treatment regimens for HIV, yet evidence remains limited for people living with HIV (PLWH) with high baseline viral load. This study aims to e...
Sepsis Recognition and Management Gaps in Hospitals: A Post Hoc Analysis of a Subset of Data from the European Sepsis Care Survey [0.03%]
对欧洲脓毒症护理调查部分数据的事后分析：医院在脓毒血症识别和管理方面的差距
Jakub Śmiechowicz,Christian S Scheer,Joanna Bartczak et al.
Jakub Śmiechowicz et al.
Introduction: Sepsis is a life-threatening condition and its management should be a hospital priority. The European Sepsis Care Survey (ESCS) investigated the implementation of guideline recommendations and the availabili...
Budget Impact of Strategies Involving RSVpreF and Nirsevimab to Protect Infants in Saudi Arabia Against Respiratory Syncytial Virus [0.03%]
关于使用RSVpreF和尼塞维马布保护沙特阿拉伯婴儿免受呼吸道合胞病毒侵害的策略的预算影响分析
Adel S Alharbi,Nada Abu-Shraie,Hana Al Abdulkarim et al.
Adel S Alharbi et al.
Introduction: Respiratory syncytial virus (RSV) manifesting as lower respiratory tract illness (LRTI; RSV-LRTI) has a significant clinical and economic impact for infants in the Kingdom of Saudi Arabia (KSA) and globally....
The Clinical and Symptomatic Burden Among Older Adults with Respiratory Syncytial Virus: A Real-World Survey in Five European Countries [0.03%]
五欧洲国家的老年人呼吸道合胞病毒临床及症状负担的真实世界调查
Diana Mendes,James Lucas,Emily Quinones et al.
Diana Mendes et al.
Introduction: Although respiratory syncytial virus (RSV) is a common cause of respiratory illness in older adults (≥ 60 years), data on overall burden remain limited. This study investigated the clinical and symptomatic ...
Real-World Data on the Use of Intravenous Fosfomycin for the Treatment of Central Nervous System Infections: a Subgroup Analysis from the FORTRESS Study [0.03%]
基于FORTRESS研究的静脉磷霉素治疗中枢神经系统感染真实世界数据分析：亚组分析
Dominik Jarczak,Stefan Kluge,Martin Kieninger et al.
Dominik Jarczak et al.
Introduction: Central nervous system (CNS) infections are associated with high morbidity and mortality, and their management is challenged by antimicrobial resistance and limited cerebrospinal fluid (CSF) penetration of m...
Efficacy Outcomes of Fecal Microbiota, Live-jslm in Preventing Recurrent Clostridioides difficile Infection from Seven Clinical Studies [0.03%]
七项临床研究中粪便微生物活菌制剂.Live-JS LM治疗复发性艰难梭菌感染的有效性分析
Teena Chopra,Daniel Van Handel,Brian Baggott et al.
Teena Chopra et al.
Clostridioides difficile infection (CDI) is one of the most common healthcare-associated infections in the US, and recurrence remains a major clinical challenge, as standard-of-care antibiotics fail to prevent recurrence in up to one-third ...
Infections in Burn Patients: Pathophysiology, Prevention, and Contemporary Therapeutic Strategies in the Era of Antimicrobial Resistance [0.03%]
烧伤患者的感染：抗菌素耐药时代的病理生理学、预防和当代治疗策略
Ana Cătălina Țânțu,Monica Marilena Țânțu,Corneliu Ovidiu Vrancianu et al.
Ana Cătălina Țânțu et al.
Burn injuries are associated with significant morbidity and mortality, largely driven by infectious complications. Disruption of the skin barrier, systemic inflammation, and postburn immunosuppression promote microbial colonization and prog...
Effectiveness, Sex Differences, and Patient Experience in Real-World Use of Long-Acting Cabotegravir and Rilpivirine: Results from a Prospective Study [0.03%]
长效卡博特egravir和Rilpivirine真实世界应用的有效性、性别差异及患者体验：一项前瞻性研究的结果
Ana González-Cordón,Júlia Calvo,Leire Berrocal et al.
Ana González-Cordón et al.
Introduction: Long-acting intramuscular cabotegravir plus rilpivirine (LA-CAB/RPV) administered every 2 months (Q2M) has been available in Spain since January 2023 as a switch strategy for HIV treatment. We evaluated char...
Publisher Correction: Modeling the Public Health Impact of Introducing 4CMenB Vaccination for Infants in the Brazilian National Immunization Program [0.03%]
正误更正：模拟4CMenB疫苗被纳入巴西国家免疫计划对公共卫生的影响模型
Thatiana Pinto,Zeki Kocaata,Ana Medina et al.
Thatiana Pinto et al.
Published Erratum
Infectious diseases and therapy. 2026 Jun 8. DOI:10.1007/s40121-026-01368-7 2026